Adriana Feder, MD, based in New York, NY, is a distinguished psychiatrist and professor specializing in trauma and resilience research at the Icahn School of Medicine at Mount Sinai. With a focus on post-traumatic stress and resilience in various populations, Dr. Feder has led groundbreaking studies on PTSD biomarkers and treatment interventions, notably contributing to the use of ketamine therapy for PTSD.
As the Director of the Trauma and Resilience Program and Associate Director for Research at the World Trade Center Mental Health Program, Dr. Feder's expertise in psychobiology and clinical epidemiology has garnered recognition in scientific circles. Her commitment to advancing knowledge in stress and trauma-related disorders underscores her position as a leading figure in the field of psychiatry.
Generated from the website